286 related articles for article (PubMed ID: 29638159)
1. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy.
Oh HJ; Nam BY; Wu M; Kim S; Park J; Kang S; Park JT; Yoo TH; Kang SW; Han SH
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F791-F805. PubMed ID: 29638159
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
3. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
4. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
[TBL] [Abstract][Full Text] [Related]
5. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes.
Kang SW; Natarajan R; Shahed A; Nast CC; LaPage J; Mundel P; Kashtan C; Adler SG
J Am Soc Nephrol; 2003 Dec; 14(12):3178-87. PubMed ID: 14638916
[TBL] [Abstract][Full Text] [Related]
6. Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection.
Lee J; Tsogbadrakh B; Yang S; Ryu H; Kang E; Kang M; Kang HG; Ahn C; Oh KH
Biochem Biophys Res Commun; 2021 Jan; 534():1040-1046. PubMed ID: 33121684
[TBL] [Abstract][Full Text] [Related]
7. Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells.
Wang Q; Ren D; Li Y; Xu G
Cell Cycle; 2019; 18(6-7):696-707. PubMed ID: 30784349
[TBL] [Abstract][Full Text] [Related]
8. Klotho inhibits PKCα/p66SHC-mediated podocyte injury in diabetic nephropathy.
Jiang W; Xiao T; Han W; Xiong J; He T; Liu Y; Huang Y; Yang K; Bi X; Xu X; Yu Y; Li Y; Gu J; Zhang J; Huang Y; Zhang B; Zhao J
Mol Cell Endocrinol; 2019 Aug; 494():110490. PubMed ID: 31207271
[TBL] [Abstract][Full Text] [Related]
9. Perilipin2 inhibits diabetic nephropathy-induced podocyte apoptosis by activating the PPARγ signaling pathway.
Dai ZW; Cai KD; Xu LC; Wang LL
Mol Cell Probes; 2020 Oct; 53():101584. PubMed ID: 32387304
[TBL] [Abstract][Full Text] [Related]
10. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
11. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.
Kadoya H; Satoh M; Haruna Y; Sasaki T; Kashihara N
Clin Exp Nephrol; 2016 Oct; 20(5):671-678. PubMed ID: 26586006
[TBL] [Abstract][Full Text] [Related]
12. Klotho attenuates high glucose-induced fibronectin and cell hypertrophy via the ERK1/2-p38 kinase signaling pathway in renal interstitial fibroblasts.
Huang JS; Chuang CT; Liu MH; Lin SH; Guh JY; Chuang LY
Mol Cell Endocrinol; 2014 Jun; 390(1-2):45-53. PubMed ID: 24721634
[TBL] [Abstract][Full Text] [Related]
13. Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions.
Lee SH; Moon SJ; Paeng J; Kang HY; Nam BY; Kim S; Kim CH; Lee MJ; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
Apoptosis; 2015 Aug; 20(8):1056-71. PubMed ID: 25953318
[TBL] [Abstract][Full Text] [Related]
14. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
Paeng J; Chang JH; Lee SH; Nam BY; Kang HY; Kim S; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
Apoptosis; 2014 Dec; 19(12):1678-90. PubMed ID: 25284613
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
Suk Kang J; Son SS; Lee JH; Lee SW; Jeong AR; Lee ES; Cha SK; Chung CH; Lee EY
PLoS One; 2021; 16(4):e0250666. PubMed ID: 33891667
[TBL] [Abstract][Full Text] [Related]
16. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
17. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.
Xu ZG; Ryu DR; Yoo TH; Jung DS; Kim JJ; Kim HJ; Choi HY; Kim JS; Adler SG; Natarajan R; Han DS; Kang SW
Nephrol Dial Transplant; 2005 Mar; 20(3):524-31. PubMed ID: 15647309
[TBL] [Abstract][Full Text] [Related]
18. Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions.
Kwak SJ; Paeng J; Kim DH; Lee SH; Nam BY; Kang HY; Li JJ; Jung DS; Han SH; Ryu DR; Park JT; Chang TI; Yoo TH; Han DS; Kang SW
Apoptosis; 2011 May; 16(5):478-90. PubMed ID: 21373934
[TBL] [Abstract][Full Text] [Related]
19. Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.
Srivastava SP; Zhou H; Setia O; Dardik A; Fernandez-Hernando C; Goodwin J
J Am Heart Assoc; 2021 Aug; 10(15):e019437. PubMed ID: 34308664
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
